In March 2025, the company declared new programs for just a direct-to-client supplying of its Wegovy weight loss drug. The company recognized a completely new pharmacy, named NovoCare, which would charge clients $499 every month for use of the drug, lower than fifty percent the price of the drug via other pharmaceutical distribution networks.[53]ar